Cardiovascular Ultrasound Systems Market Size - By Type (Transthoracic Echocardiography, Transesophageal Echocardiography, Stress Echocardiogram), By Technology (2D, 3D/4D, Doppler), By Display (Black & White (B/W) Display), By End-use – Global Forecast to 2032

Cardiovascular Ultrasound Systems Market Size - By Type (Transthoracic Echocardiography, Transesophageal Echocardiography, Stress Echocardiogram), By Technology (2D, 3D/4D, Doppler), By Display (Black & White (B/W) Display), By End-use – Global Forecast to 2032

Cardiovascular Ultrasound Systems Market Size

Cardiovascular Ultrasound Systems Market size was valued at USD 1.8 billion in 2022 and is projected to reach USD 3.1 billion by 2032. Cardiovascular ultrasound systems, also known as echocardiography systems or cardiac ultrasound systems, are medical imaging devices specifically designed for assessing the structure and function of the heart and blood vessels.
 

They use ultrasound technology to generate real-time images of the cardiovascular devices, allowing healthcare professionals to visualize and evaluate the heart's anatomy, blood flow, and cardiac function. Additionally, technological advancements in cardiovascular ultrasound systems have been significant in recent years, enabling improved imaging capabilities, increased efficiency, and enhanced diagnostic accuracy.
 

Several diagnostic ultrasound systems are becoming portable and user-friendly, allowing for immediate and convenient bedside examinations. Additionally, point-of-care ultrasound (POCUS) has gained prominence in healthcare settings, including emergency departments, critical care units, and outpatient clinics.
 

COVID-19 Impact

The COVID-19 pandemic had a significant impact on the cardiovascular ultrasound systems market. During the pandemic, many healthcare facilities experienced disruptions in routine services, including elective procedures and non-urgent diagnostic tests. This led to a decrease in the number of cardiovascular ultrasound procedures being performed, affecting the demand for cardiovascular ultrasound systems. Moreover, due to lockdowns, travel restrictions, and concerns regarding potential exposure to the virus, many individuals postponed routine screenings and follow-up visits, including cardiovascular ultrasound examinations. This led to a decline in the number of procedures being performed, affecting the utilization of cardiovascular ultrasound systems.
 

Cardiovascular Ultrasound Systems Market Trends

The rising incidence of cardiovascular diseases, including heart conditions, vascular disorders, and hypertension, is driving the demand for cardiovascular ultrasound systems. These systems play a crucial role in diagnosing, monitoring, and managing cardiovascular conditions. According to the World Health Organization (WHO), cardiovascular diseases are the number one cause of death globally, accounting for an estimated 20.5 million deaths in 2021. Further, the incidence of cardiovascular diseases is increasing, partially due to factors such as sedentary lifestyles, unhealthy diets, tobacco use, obesity, and an increasing aging population base. This rise in incidence contributes to the growing demand for cardiovascular ultrasound systems for medical imaging purpose.
 

Cardiovascular Ultrasound Systems Market Analysis

Based on type, the cardiovascular ultrasound systems market is segmented into transthoracic echocardiography, transesophageal echocardiography, stress echocardiogram, and others. The transthoracic echocardiography segment witnessed the largest revenue size of USD 998.8 million in 2022 and is estimated to USD 1,686.3 million by 2032. Transthoracic echocardiography (TTE) is a widely used imaging technique in cardiology for evaluating the structure and function of the heart. TTE provides comprehensive information about the structure and function of the heart. It allows for the assessment of cardiac chambers, valves, myocardial function, and blood flow patterns. TTE is valuable in diagnosing and evaluating a wide range of cardiac conditions, including valvular heart diseases, heart failure, myocardial infarction, congenital heart defects, and cardiomyopathies. The diagnostic versatility of TTE contributes to its widespread use and demand.
 

Based on technology cardiovascular ultrasound systems market is bifurcated into doppler, 3/4D, and 2D. The doppler segment is anticipated to reach over USD 1.2 billion by 2032. Doppler ultrasound systems offer a non-invasive method to assess blood flow in real-time. This feature allows healthcare professionals to evaluate blood flow patterns, detect obstructions or abnormalities, and assess vascular conditions without the need for invasive procedures. Moreover, doppler ultrasound systems offer a cost-effective and safe imaging modality compared to other imaging techniques like computed tomography (CT) or magnetic resonance imaging (MRI). This makes them a preferred choice for screening, follow-up, and routine assessments, particularly in resource-constrained settings.
 

Based on display cardiovascular ultrasound systems market is bifurcated into colour display, black & white (B/W) display. The black & white (B/W) display segment is anticipated to reach over USD 2.5 billion by 2032. Black & white displays are well-suited for showcasing contrast and grayscale resolution, which are crucial in cardiac ultrasound imaging. They allow clear differentiation between different tissue types, blood flow, and anatomical structures within the heart, providing detailed images for accurate diagnosis. Furthermore, B/W displays are generally more cost-effective compared to colour displays. This can be advantageous for healthcare facilities, especially in resource-constrained settings or during cost considerations are important. It allows for more accessible and affordable cardiac ultrasound systems without compromising essential image quality.
 

The cardiovascular ultrasound systems market is segmented by end-use into hospitals, diagnostic centers, ambulatory care centers, and others. Hospitals segment accounting for more than 43% market share in 2022. Ultrasound systems are commonly used in hospitals for non-invasive imaging of the heart. These systems utilize ultrasound technology to produce real-time images of the heart's structure and function. The increasing prevalence of cardiovascular diseases coupled with availability of professionals in this healthcare setting to offer varied and advanced treatment.
 

U.S. cardiovascular ultrasound systems market accounted for over USD 650 million in 2022 and is projected to grow momentously over the forecast period. The development is majorly attributable to rapid technological advancements in ultrasound systems along with increasing number of cardiovascular diseases, such as heart disease and stroke. Additionally, the aging population base in the U.S. has been a significant driver of healthcare demand, including cardiovascular care. Moreover, as individuals age, the risk of developing cardiovascular diseases increases.
 

Cardiovascular Ultrasound Systems Market Share

Some of the notable key cardiovascular ultrasound systems market players operating in the cardiovascular ultrasound systems industry include

• GE Healthcare
• Koninklijke Philips
• Siemens Healthineers AG
• Hitachi Medical Corp.
• Samsung Medison Co. Ltd.
• Shenzhen Mindray Bio
• Medical Electronics Co., Ltd. (Mindray)
• Health Catalyst (KPI Healthcare Inc.)
• Fujifilm Sonosite, Inc.
• Canon Medical Systems Corporation
• Esaote SpA
   

Cardiovascular ultrasound systems Industry News

• In May 2022, Royal Philips launched EchoNavigator 4.0 company’s latest generation of advanced image-guided therapy solution for the treatment of structural heart disease. This has helped company to strengthen its product portfolio and market position.
   

Cardiovascular ultrasound systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Type (USD Million)

• Transthoracic echocardiography
• Transesophageal echocardiography
• Stress echocardiogram
• Others

By Technology (USD Million)

• 2D
• 3D/4D
• Doppler

By Display (USD Million)

• Colour display
• Black & white (B/W) display

By End-use (USD Million)

• Hospital
• Diagnostic centers
• Ambulatory care centers
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Poland
  • Switzerland
  • Norway
  • Finland
  • Sweden
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Taiwan
  • Indonesia
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Israel